CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM
CNLM was delisted on the 8th of June, 2016.
6 hedge funds and large institutions have $14.8M invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$5.37M |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$2.62M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$2.15M |
| 4 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$1.17M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$195 |
Top Sellers
CNLM Hedge Fund Activity: Q1 2015 in Review
6 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) for Q1 2015, worth a combined $14.8M.
Buyers outnumbered sellers: 6 funds opened new CNLM positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $5.37M.
- 6 institutional investors held CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) as of Q1 2015, up from 0 in Q4 2014.
- Funds reported $14.8M of CB PHARMA ACQUISISTION CORP SHS (CYM) stock for Q1 2015.
- 6 funds opened new CB PHARMA ACQUISISTION CORP SHS (CYM) positions in Q1 2015 and 0 closed out, a net change of +6 holders.
- The largest CB PHARMA ACQUISISTION CORP SHS (CYM) buyer in Q1 2015 was Polar Asset Management Partners, an estimated $5.37M added.
Based on aggregated 13F filings for Q1 2015.